dc.contributor.author | Ormerod, Anthony D. | |
dc.contributor.author | Thomas, Kim S. | |
dc.contributor.author | Craig, Fiona E. | |
dc.contributor.author | Mitchell, Eleanor | |
dc.contributor.author | Greenlaw, Nicola | |
dc.contributor.author | Norrie, John | |
dc.contributor.author | Mason, James M. | |
dc.contributor.author | Walton, Shernaz | |
dc.contributor.author | Johnston, Graham A. | |
dc.contributor.author | Williams, Hywel C. | |
dc.contributor.author | Uk Dermatology Clinical Trials Net | |
dc.date.accessioned | 2015-10-27T11:45:01Z | |
dc.date.available | 2015-10-27T11:45:01Z | |
dc.date.issued | 2015-06-12 | |
dc.identifier.citation | Ormerod , A D , Thomas , K S , Craig , F E , Mitchell , E , Greenlaw , N , Norrie , J , Mason , J M , Walton , S , Johnston , G A , Williams , H C & Uk Dermatology Clinical Trials Net 2015 , ' Comparison of the two most commonly used treatments for pyoderma gangrenosum : results of the STOP GAP randomised controlled trial ' , BMJ , vol. 350 , 2958 . https://doi.org/10.1136/bmj.h2958 | en |
dc.identifier.issn | 1756-1833 | |
dc.identifier.other | PURE: 58137492 | |
dc.identifier.other | PURE UUID: e44be70f-ff75-4573-8828-cb4dd32e7a4e | |
dc.identifier.other | WOS: 000356391300001 | |
dc.identifier.other | Scopus: 84936770257 | |
dc.identifier.uri | http://hdl.handle.net/2164/5115 | |
dc.description | Funding: This publication presents independent research funded by the National Institute for Health Research (NIHR) under its programme grants for applied research (RP-PG-0407-10177). | en |
dc.format.extent | 8 | |
dc.language.iso | eng | |
dc.relation.ispartof | BMJ | en |
dc.rights | This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by. | en |
dc.subject | inflammatory-bowel-disease | en |
dc.subject | United-Kingdom | en |
dc.subject | cyclosporine | en |
dc.subject | therapy | en |
dc.subject | multicenter | en |
dc.subject | management | en |
dc.subject | diagnosis | en |
dc.subject | update | en |
dc.subject | index | en |
dc.subject | R Medicine | en |
dc.subject | National Institute for Health Research (NIHR) | en |
dc.subject.lcc | R | en |
dc.title | Comparison of the two most commonly used treatments for pyoderma gangrenosum : results of the STOP GAP randomised controlled trial | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1136/bmj.h2958 | |